首页>投融资
NeuroTherapia
B轮
NeuroTherapia is a company focused on the treatment of neuroinflammatory diseases which was created in 2015 as a spin off from the Cleveland Clinic based on research by Drs Mohamed Naguib and Joseph Foss.In September 2020, NeuroTherapia closed Series A financing of $8.8 million led by Brain Trust Accelerator Fund II.In October 2015, the company had raised $1M in funding,
基本信息
-
公司全称NeuroTherapia Inc
-
类型受体激动剂研发商
-
产业领域药品研发/制造、化学药
-
公司人数15人以下
-
地址1500 Chagrin River Road GATES MILLS OHIO 44040; US; Telephone: +1216870796;
-
联系电话1216870796
-
邮箱info@neurotherapia.com
-
成立时间2015-01-01
投融资
-
2024-08-06B轮1230万美元Cleveland ClinicBrain Trust Accelerator Fund II杜比创投Alzheimer's Drug Discovery FoundationFoundation for a Better WorldCRUINT
-
2020-09-22A轮880万美元Brain Trust Accelerator Fund IICleveland Clinic FoundationAlzheimer's Drug Discovery Foundation杜比创投
相关投融资企业
A轮
Tasca Therapeuticstasca是一家私营生物技术公司，专注于发现和开发在癌症中很重要的自棕榈酰化靶蛋白的小分子抑制剂。该公司的主导项目CP-383是同类首创的候选药物，对多种癌症类型具有很好的临床前活性。
A轮
Ambrosia Biosciences Inc.是一家私营药物发现公司，开发口服小分子疗法治疗肥胖症和其他代谢紊乱。该公司的平台为体重管理和代谢健康提供非侵入性方法，与一些传统药物相比，使患者能够有效地管理自己的病情，副作用更少。
种子轮
RenaissThera is a pharmaceutical company focused on developing affordable and innovative therapies, particularly targeting high unmet medical needs in areas like cardio-metabolic disorders, oncology, and immunology. Additionally, Renaiss Thera utilizes generative AI to accelerate drug discovery and target identification.
浙公网安备33011002015279
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息